ROS1 and neoplasm: The oncogenic signaling pathway mutations consisted of KRAS, EGFR, and ALK/ROS1/RET mutations, which play crucial roles in cell proliferation and are associated with tumor aggressiveness and a higher risk of recurrence [51,52,53].